BEBT-738

N/A

Report date: 2026/03/13 20:02:36

NME

Base Information

Drug NameBEBT-738

Drug Alias NameBEBT-738BEBT738

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate

Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors

TargetsSodium/glucose cotransporter 2

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGuangzhou BeBetter Medicine Technology Co

China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou BeBetter Medicine Technology Co

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus

Inactive IndicationsN/A

Other Information

ATC CodeN/A